Cardinal Health (NYSE:CAH) Price Target Raised to $150.00 at Mizuho

Cardinal Health (NYSE:CAH) had its target price hoisted by Mizuho from $142.00 to $150.00 in a research note issued to investors on Monday morning,Benzinga reports. They currently have an outperform rating on the stock.

A number of other research firms have also recently issued reports on CAH. TD Cowen upgraded Cardinal Health from a “hold” rating to a “buy” rating and increased their target price for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective for the company in a report on Tuesday, January 7th. Argus set a $148.00 target price on Cardinal Health in a research note on Tuesday, February 4th. Citigroup raised their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research note on Friday, January 10th. Finally, Jefferies Financial Group raised shares of Cardinal Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average price target of $140.14.

Cardinal Health Price Performance

NYSE:CAH opened at $137.83 on Monday. The business’s 50-day simple moving average is $128.60 and its 200-day simple moving average is $121.03. Cardinal Health has a fifty-two week low of $93.17 and a fifty-two week high of $138.62. The stock has a market capitalization of $33.29 billion, a PE ratio of 25.71, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, research analysts expect that Cardinal Health will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.47%. Cardinal Health’s dividend payout ratio is 37.69%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Cyrus J. Lawrence LLC bought a new position in Cardinal Health during the fourth quarter worth $26,000. Promus Capital LLC acquired a new stake in shares of Cardinal Health during the 4th quarter worth about $30,000. Bellwether Advisors LLC bought a new stake in shares of Cardinal Health during the 4th quarter worth about $32,000. Lee Danner & Bass Inc. acquired a new position in Cardinal Health in the 4th quarter valued at about $35,000. Finally, Itau Unibanco Holding S.A. bought a new position in Cardinal Health in the 4th quarter valued at about $36,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.